Press release
Respiratory Drugs And Devices Market Size, Competitive Analysis, Share, Forecast- 2018-2023
Respiratory Drugs And Devices Market
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/respiratory-drugs-devices-market
Factors that are augmenting the market include predominance of chronic respiratory diseases such as asthma, COPD and so on, overgrowing geriatric population, changing lifestyle activities among people and innovations and development of new products. Asthma is one of the major non-communicable diseases globally affect almost each major economy. As per WHO, about 235 million people have asthma related diseases globally. It is most common communicable disease in children however maximum mortalities are observed in elderly population. It is highly prevalent in high-income countries however developing economies share a large part of mortalities.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/respiratory-drugs-devices-market
Another major factor that is expanding respiratory drug and device market size is overgrowing geriatric population in the major economies of the globe. People of this age group are more prone to respiratory diseases such as Asthma and COPD. As per World Bank, in 2010, geriatric population were 7.6% in 2010 which was equal to 524 million and it has been increased to 8.4% in 2016. It is forecast that it will reach 1.5 billion in 2050 with a share of 16% of total population. More notable point is that, developed and technological advance economies have higher percentage of geriatric population as compare to developing economies & global average.
Moreover, as per Centre for Diseases Control and Prevention, about 11.5 million asthma attacks were observed in 2015 including 3 million in children in the US. As per Asthma UK, about 5.4 million people are suffering from asthma in the UK in 2016. Out of 5.4 million people, asthma is prevalent in 4.3 million adults and 1.1 million in children. As per WHO, India is estimated to have about 15-20 million asthma patients in 2017. It is also on high rise in China, as per Asia Asthma Development Board, there were about 36.7 patients of asthma per 100,000 people. There are more than 30 million people living with Asthma in the China. These facts and figures address the demand for respiratory drugs and devices; thereby, expanding the global market size.
Global Respiratory Drugs and Devices Market Segmentation
By Type
Drugs
Devices
Global Respiratory Drugs and Devices Market – Segment by Region
North America
US
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Latin America
Middle East and Africa
COMPANY PROFILES
ASTRAZENECA
ADAMIS (ADMP)
ADS BIOTECHNOLOGY
AIR LIQUIDE
ALIOS BIOPHARMA INC.
ALUNG TECHNOLOGIES
ALVOGEN
ANAXSYS
APPLIED BIOCODE INC
APTIMMUNE BIOLOGICS INC
APTUIT
ARADIGM
AROS PHARMA APS
ARROW THERAPEUTICS, LTD.
AVITA MEDICAL
BAXTER INTERNATIONAL
BAYER AG
BEXIMCO PHARMACEUTICALS LTD
BIOMARCK PHARMACEUTICALS, LTD
BIOXYDYN LIMITED
BOEHRINGER INGELHEIM
CAPELLON PHARMACEUTICALS, LTD.
CHART INDUSTRIES
CHIESI FARMACEUTICI S.P.A
CIRCADIANCE
CIRCASSIA.
CIVITAS THERAPEUTICS, INC.
COMPUMEDICS LIMITED
COVIDIEN PLC
DAINIPPON SUMITOMO PHARMA CO., LTD.
DRAGER MEDICAL GMBH
EDIMER PHARMACEUTICALS
EDIXOMED LTD.
ENANTA PHARMACEUTICALS
FARON
FISHER AND PAYKEL HEALTHCARE CORP. LTD
GE HEALTHCARE LIMITED
GECKO HEALTH INNOVATIONS, INC.
GILBERT TECHNOLOGIES
GILEAD SCIENCES, INC.
GLAXOSMITHKLINE
GRIFOLS
H&T PRESSPART
HAMILTON MEDICAL AG
INVACARE CORPORATION
MERCK AND CO.
MERIDIAN BIOSCIENCE
METHAPHARM
MICROBOT MEDICAL
MYLAN
NABRIVA THERAPEUTICS
NEPHRON PHARMACEUTICALS CORPORATION
NOVABIOTICS
NOVALUNG
NOVARTIS AG
NOX MEDICAL
ONCOLYTICS BIOTECH
OPKO HEALTH
OREXO
ORION CORPORATION
OTSUKA PHARMACEUTICALS
OXAGEN LIMITED
OXEHEALTH
PALOBIOFARMA SL
PATARA PHARMA
PATHWAY THERAPEUTICS LTD
PEPTINNOVATE
PFIZER
PHARMAXIS
PHARMAXIS
PHILIPS HEALTHCARE
PIERIS PHARMACEUTICALS
PLAIR SA
PMD SOLUTIONS
PNEUMACARE LIMITED
PROPELLER HEALTH
PULMOTECT, INC.
REPLICOR
RESPEQ
RESPICARDIA
RESPIRATORY MOTION
ROCHE DIAGNOSTICS
SAVARA INC.
SIME DIAGNOSTICS LTD
SUNOVION PHARMACEUTICALS INC
SYNAIRGEN
SYNAPSE BIOMEDICAL
TAKEDA PHARMACEUTICAL COMPANY LIMITED,
TECHNO DRUGS LTD.
TEICOS PHARMA OY
TEIJIN PHARMA LTD.
TEVA PHARMACEUTICALS
TOTALCARE EHEALTH
VALEANT PHARMACEUTICALS
VAPOTHERM
VENTIRX PHARMACEUTICALS, INC.
VERONA PHARMA PLC
VERTEX PHARMACEUTICALS
VIDA THERAPEUTICS INC.
VIRIONHEALTH LIMITED
VIROBLOCK SA
VIROCLINICS BIOSCIENCES B.V.
WINDTREE THERAPEUTICS
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/respiratory-drugs-devices-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Respiratory Drugs And Devices Market Size, Competitive Analysis, Share, Forecast- 2018-2023 here
News-ID: 2221157 • Views: …
More Releases from Orion Market Research
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033.
Road Marking Paint Market Overview
The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new…
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period.
Outboard Boat Market Overview
The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including…
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033.
Mobile Ticketing Market Overview
The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,…
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033.
Metal Alloy Market Overview
The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in…
More Releases for PHARMA
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
